139 related articles for article (PubMed ID: 26753940)
1. 3-D tissue modelling and virtual pathology as new approaches to study ductal carcinoma in situ.
Booth ME; Nash CE; Roberts NP; Magee DR; Treanor D; Hanby AM; Speirs V
Altern Lab Anim; 2015 Dec; 43(6):377-83. PubMed ID: 26753940
[TBL] [Abstract][Full Text] [Related]
2. Ductal carcinoma in situ of breast: update 2019.
Badve SS; Gökmen-Polar Y
Pathology; 2019 Oct; 51(6):563-569. PubMed ID: 31472981
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence.
Sinha VC; Piwnica-Worms H
J Mammary Gland Biol Neoplasia; 2018 Dec; 23(4):191-205. PubMed ID: 30194658
[TBL] [Abstract][Full Text] [Related]
4. Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation.
Farshid G; Moinfar F; Meredith DJ; Peiterse S; Tavassoli FA
Virchows Arch; 2001 Jul; 439(1):70-7. PubMed ID: 11499843
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
6. [Ductal carcinoma in situ].
Skaar M; Langhans L; Mertz B; Kroman N
Ugeskr Laeger; 2018 Sep; 180(38):. PubMed ID: 30259839
[TBL] [Abstract][Full Text] [Related]
7. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
[TBL] [Abstract][Full Text] [Related]
8. Ductal carcinoma in situ: a disease entity that merits more recognition.
Dereere E; Papadimitriou K; Tjalma W; Altintas S
Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
[TBL] [Abstract][Full Text] [Related]
9. Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma.
Nadrljanski M; Maksimović R; Plešinac-Karapandžić V; Nikitović M; Marković-Vasiljković B; Milošević Z
Eur J Radiol; 2014 Aug; 83(8):1363-7. PubMed ID: 24894697
[TBL] [Abstract][Full Text] [Related]
10. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
11. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
[TBL] [Abstract][Full Text] [Related]
12. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
[TBL] [Abstract][Full Text] [Related]
13. The molecular journey from ductal carcinoma in situ to invasive breast cancer.
Wiechmann L; Kuerer HM
Cancer; 2008 May; 112(10):2130-42. PubMed ID: 18383519
[TBL] [Abstract][Full Text] [Related]
14. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.
Kerlikowske K; Molinaro A; Cha I; Ljung BM; Ernster VL; Stewart K; Chew K; Moore DH; Waldman F
J Natl Cancer Inst; 2003 Nov; 95(22):1692-702. PubMed ID: 14625260
[TBL] [Abstract][Full Text] [Related]
15. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Groen EJ; Elshof LE; Visser LL; Rutgers EJT; Winter-Warnars HAO; Lips EH; Wesseling J
Breast; 2017 Feb; 31():274-283. PubMed ID: 27671693
[TBL] [Abstract][Full Text] [Related]
16. Pathology of ductal carcinoma in situ of the breast: a heterogeneous entity in need of greater understanding.
Tan PH
Ann Acad Med Singap; 2001 Nov; 30(6):671-6; quiz 677. PubMed ID: 11817303
[TBL] [Abstract][Full Text] [Related]
17. Breast ductal carcinoma in situ with micro-invasion versus ductal carcinoma in situ: a comparative analysis of clinicopathological and mammographic findings.
Zhang M; Lin Q; Su XH; Cui CX; Bian TT; Wang CQ; Zhao J; Li LL; Ma JZ; Huang JL
Clin Radiol; 2021 Oct; 76(10):787.e1-787.e7. PubMed ID: 34052010
[TBL] [Abstract][Full Text] [Related]
18. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
[TBL] [Abstract][Full Text] [Related]
19. Ductal carcinoma in situ of the breast: a new phenotype classification system and its relation to prognosis.
Wärnberg F; Casalini P; Nordgren H; Bergkvist L; Holmberg L; Ménard S
Breast Cancer Res Treat; 2002 Jun; 73(3):215-21. PubMed ID: 12160327
[TBL] [Abstract][Full Text] [Related]
20. Recognizing breast ductal carcinoma in situ on fine-needle aspiration: a diagnostic dilemma.
Guo HQ; Zhang ZH; Zhao H; Zhao LL; Pan QJ
Diagn Cytopathol; 2013 Aug; 41(8):710-5. PubMed ID: 23729369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
